Http://msds.farnam.com/m001830.htm
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Return to MSDS List , First MSDS in list. , Last MSDS in list.
M A T E R I A L S A F E T Y D A T A S H E E T
Generated 07/21/2010,
Revision 07/21/2010,
Supercedes Revision 11/12/2009,
Date
Created 11/12/2009
SECTION 1. Product and Company Identification
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Product Code: HH-IVER
Product Name:
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Reference #: ANADA
Manufacturer Information Company Name: Distributed
Emergency Contact:
Alternate Emergency
Contact: Information:
Preparer Name: S
Additional Identity Information 100503595 6.08g (0.21 oz) box packaging
100503652 6.08g (0.21 oz) cello packaging
SECTION 2. Composition/Information on Ingredients
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Hazardous Components (Chemical Name)
Concentration
methylpropyl)-22,23-dihydro-25-(1-methylethyl)-
SECTION 3. Hazards Identification
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Emergency Overview KEEP OUT OF REACH OF CHILDREN
Route(s) of Entry:
Inhalation? N.A. , Skin? Yes , Eyes? Yes , Ingestion? Yes
Potential Health Effects (Acute and Chronic) None known
Signs and Symptoms Of Exposure None known
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Medical Conditions Generally Aggravated By Exposure None known
SECTION 4. First Aid Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Emergency and First Aid Procedures IF INGESTED: If accidental ingestion occurs, get medical attention immediately.
IF IN EYES: Immediately flush eyes with plenty of water for 15 minutes. Seek medical attention if
irritation persists.
IF ON SKIN: Wash contact area with soap and water. Remove contaminated clothing and wash before
reuse. If irritation occurs or persists, get medical attention.
Note to Physician None
SECTION 5. Fire Fighting Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Flash Pt: NA
Explosive Limits:
Autoignition Pt: NA
Fire Fighting Instructions Firefighters should wear self-contained breathing apparatus and full protective equipment.
Flammable Properties and Hazards None known
Hazardous Combustion Products None known
Extinguishing Media Use water spray or all purpose dry chemical.
Unsuitable Extinguishing Media None known
SECTION 6. Accidental Release Measures
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Steps To Be Taken In Case Material Is Released Or Spilled Shovel spill into disposal containers. Rinse spill site with detergent and water. Use suitable protective
gear.
SECTION 7. Handling and Storage
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Precautions To Be Taken in Handling Do Not Smoke. Avoid contact with eyes, skin and clothing. Wash hands after use.
Precautions To Be Taken in Storing Store in cool dry place away from heat and sunlight.
Other Precautions
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Refrain from smoking and eating when handling. Wash hands after use. Avoid contact with eyes.
SECTION 8. Exposure Controls/Personal Protection
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Respiratory Equipment (Specify Type) None
Eye Protection Wear safety goggles
Protective Gloves Wear rubber gloves
Other Protective Clothing None needed except for manufacturing situations or large spills of product.
Engineering Controls (Ventilation etc.) Local exhaust sufficient.
Work/Hygienic/Maintenance Practices Wash hands before eating, smoking, or using restroom.
SECTION 9. Physical and Chemical Properties
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Physical States:
Melting Point: NA
Boiling Point: NA
Autoignition Pt: NA
Flash Pt: NA
Explosive Limits:
Specific Gravity (Water = 1):
Density:
Bulk density:
Vapor Pressure (vs. Air or mm NA
Hg): Vapor Density (vs. Air = 1):
Evaporation Rate (vs Butyl
Acetate=1): Solubility in Water: No
Solubility Notes Dispersible
Percent Volatile: NA
VOC / Volume: NA
Heat Value:
Particle Size:
Corrosion Rate:
Appearance and Odor Clear, colorless paste
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 10. Stability and Reactivity
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Stability:
Conditions To Avoid - Instability NE
Incompatibility - Materials To Avoid None known
Hazardous Decomposition Or Byproducts None known
Hazardous Polymerization:
Conditions To Avoid - Hazardous Polymerization None known
SECTION 11. Toxicological Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
No data available
Carcinogenicity/Other Information Ivermectin is not listed as a carcinogen with NTP, OSHA, or IARC.
Hazardous Components (Chemical Name)
NTP IARC ACGIH OSHA
Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)-
Carcinogenicity:
NTP? No IARC Monographs? No OSHA Regulated? No
SECTION 12. Ecological Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Ivermectin and excreted ivermectin residues may adversely affect aquatic organisms. Do not contaminate ground or surface water. Dispose of the syringe in an approved landfill or by incineration.
SECTION 13. Disposal Considerations
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Waste Disposal Method Dispose of in accordance with local, state and federal regulations.
SECTION 14. Transport Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
LAND TRANSPORT (US
DOT) DOT Proper Shipping Name Not regulated as hazardous by U.S. DOT.
DOT Hazard Label: None
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 15. Regulatory Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 16. Other Information
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Company Policy or Disclaimer The information and data herein are believed to be accurate and have been compiled from sources
believed to be reliable. It is offered for your consideration, investigation and verification.
Source: http://www.horse.com/ContentFiles/Associated_Content/HHIvermectinMSDS.pdf
Gesundheit Departement Gesundheit ZHAW Publikationsliste 2007 23. 05. 2008 Die fett markierten (Ko-) AutorInnen sind Mitarbeitende des Departements Gesundheit. 1. Publikationen referierten Zeitschriften (mit Peer Review) Brodbeck, J., Matter, M., Page, J. & Moggi, F. (2007). Motives for cannabis use as a moderator variable of distress among young adults.
Editorial Commentary Migrainous stroke Reports of migraine-associated stroke appear in the medical literature with regularity, but uncertainty persists as to themechanisms which may generate this uncommon complication of a common condition. In their article in this issue Drs Saninand Mathew describe a patient with migrainous stroke and arteriographic findings consistent with diffuse cerebral